Machine Learning

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.

With battery fires on the rise, Wanxiang A123 has unveiled a new semi-solid-state and immersion-cooled system designed to eliminate thermal runaway.

ASUS's new PE1000U packs Intel Core Ultra 2 power into a tiny, fanless chassis, aiming to accelerate AI at the rugged industrial edge.

A new partnership, featured on the Nasdaq Tower, combines AI e-commerce with specialized payment solutions to tackle the complexities of cross-border trade.

A new cancer drug using DNA fragments to deliver chemotherapy more safely has been cleared for US trials, offering hope for less toxic treatments.

A new report predicts autonomous AI agents will soon run marketing, transforming brand-consumer relationships and the very role of the CMO. Are you ready?

ACG becomes the first pharma packaging firm in the WEF's elite Lighthouse Network, using AI to slash defects and energy use, setting a new global standard.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Ascentage Pharma's next-gen BTK degrader, APG-3288, receives dual IND clearance, paving the way for clinical trials to fight resistant blood cancers.

Recognized as a Major Player by IDC, South Korea's SK shieldus leverages its AI platform to expand globally and serve businesses of all sizes.

Hawk Ridge Systems expands its portfolio with Stratasys' production-grade 3D printing, aiming to dominate the end-to-end additive manufacturing market.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

The logistics giant declared its quarterly dividend, continuing a 25+ year streak of increases, backed by strong financials and innovative AI strategies.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

Ex-Joint Chiefs Vice Chair Admiral Grady joins Domino Data Lab's board, signaling a major push to accelerate AI for U.S. national security missions.

Kyvos's G2 Momentum Leader award, based on user reviews, highlights the critical role of semantic layers in making enterprise AI trustworthy and cost-effective.